Bridgeway Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.5K | Hold |
33,400
| – | – | ﹤0.01% | 1087 |
|
|
2025
Q1 | $113K | Hold |
33,400
| – | – | ﹤0.01% | 1017 |
|
|
2024
Q4 | $138K | Hold |
33,400
| – | – | ﹤0.01% | 1065 |
|
|
2024
Q3 | $83.2K | Hold |
33,400
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q2 | $88.2K | Buy |
+33,400
| New | +$88.2K | ﹤0.01% | 1169 |
|
|
2017
Q1 | – | Sell |
-617
| Closed | -$98K | – | 1408 |
|
|
2016
Q4 | $98K | Sell |
617
-2,178
| -78% | -$346K | ﹤0.01% | 1358 |
|
|
2016
Q3 | $693K | Buy |
2,795
+2,178
| +353% | +$540K | 0.01% | 946 |
|
|
2016
Q2 | $551K | Buy |
617
+247
| +67% | +$221K | 0.01% | 1003 |
|
|
2016
Q1 | $337K | Buy |
370
+308
| +497% | +$281K | 0.01% | 1183 |
|
|
2015
Q4 | $87K | Hold |
62
| – | – | ﹤0.01% | 1382 |
|
|
2015
Q3 | $104K | Hold |
62
| – | – | ﹤0.01% | 1391 |
|
|
2015
Q2 | $133K | Buy |
+62
| New | +$133K | ﹤0.01% | 1408 |
|